Ligand Pharmaceuticals
LGND
#4394
Rank
โ‚น160.94 B
Marketcap
โ‚น8,810
Share price
1.28%
Change (1 day)
67.82%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): โ‚น128.34

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น131.71. In 2022 the company made an earnings per share (EPS) of -โ‚น166.11 a decrease over its 2021 EPS that were of โ‚น290.27.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น128.34-177.26%
2022-โ‚น166.11-157.23%
2021โ‚น290.27-2571.43%
2020-โ‚น11.75-100.46%
2019โ‚น2,568353.48%
2018โ‚น566.281025%
2017โ‚น50.34-700%
2016-โ‚น8.39-100.87%
2015โ‚น969.811859.32%
2014โ‚น49.505.36%
2013โ‚น46.988.0704505322479E+18%
2012โ‚น0.0000000000-100%
2011โ‚น41.11-194.23%
2010-โ‚น43.62548.38%
2009-โ‚น6.73-98.7%
2008-โ‚น518.46-136.52%
2007โ‚น1,419-787.8%
2006-โ‚น206.38-14.58%
2005-โ‚น241.61-21.31%
2004-โ‚น307.05-55.15%
2003-โ‚น684.5781.33%
2002-โ‚น377.522.74%
2001-โ‚น367.45-45.93%
2000-โ‚น679.54-14.56%
1999-โ‚น795.31-45.52%
1998-โ‚น1,460-3.97%
1997-โ‚น1,520132.31%
1996-โ‚น654.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,187 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น30.20-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น293.69 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น152.83 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น156.04 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น455.48 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น333.06 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น429.54 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,182 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA